Skip to main content
. 2023 Dec 18;6(4):pbad033. doi: 10.1093/pcmedi/pbad033

Figure 1.

Figure 1.

Precision medicine in IBD. Based on risk stratification by analyzing the determinants of disease course and treatment response including clinical, genetic, epigenetic, serological and fecal markers, physicians then select a targeted therapy and apply precision monitoring for individual patient. IBD: inflammatory bowel disease.